Bioorganic & Medicinal Chemistry Letters 2010-01-01

Novel P2-P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategy.

Marco Pompei, Maria Emilia Di Francesco, Silvia Pesci, Uwe Koch, Sue Ellen Vignetti, Maria Veneziano, Paola Pace, Vincenzo Summa

Index: Bioorg. Med. Chem. Lett. 20(1) , 168-74, (2010)

Full Text: HTML

Abstract

Hepatitis C represents a serious worldwide health-care problem. Recently, we have disclosed a novel class of P2-P4 macrocyclic inhibitors of NS3/4A protease containing a carbamate functionality as capping group at the P3 N-terminus. Herein we report our work aimed at further depeptidizing the P3 region by replacement of the urethane function with a succinamide motif. This peptidomimetic approach has led to the discovery of novel P2-P4 macrocyclic inhibitors of HCV NS3/4A protease with sub-nanomolar enzyme affinities. In addition to being potent inhibitors of HCV subgenomic replication, optimized analogues within this series have also presented attractive PK properties and showed promising liver levels in rat following oral administration.Copyright 2009 Elsevier Ltd. All rights reserved.